# R-60 — DocBright Online Dermatology

A photo-based dermatology service with standard and priority fees, separate pharmacy charges, and a stated reassessment requirement. The strength of its public offer is the definition of what the visit includes.

- **Canonical:** https://www.30plusskin.care/reviews/docbright-online-dermatology-review
- **Site:** 30+/SKIN — Skincare, published as a spec sheet.
- **Issue:** ISSUE NO. 13 / REV. 2026.10
- **Standing terms:** INDEPENDENT · AFFILIATE-FUNDED · NOT MEDICAL ADVICE

---

## Verdict

- **Stance:** CONDITIONAL — Worth buying for a specific person with a specific problem. Read who.
- **Weighted score:** 85/100 across 15% of the scoring model
- **Score scope:** DISCLOSURE ONLY
- **Category:** PRESCRIPTION ACCESS / DERMATOLOGY SERVICE
- **Price:** $59 — STANDARD VISIT · MEDICATION EXTRA
- **Container size:** DEPENDS ON PRESCRIPTION
- **Prescription:** yes
- **Compounded:** no
- **Assessment basis:** DESK REVIEW
- **Last updated:** 2026-09-13
- **Manufacturer page:** https://www.docbright.com/

DocBright publishes the visit price, messaging window and ongoing-prescription reassessment requirement together. That makes the offer easier to budget than an undefined promise of ongoing access.

Priority buys an earlier advertised review, not a different medication or independently demonstrated quality of care. We assess the terms, with no patient-service test.

## Actives, as published

_None on file._

## Scoring

| Criterion | Weight | Score | Note |
| --- | --- | --- | --- |
| EVIDENCE FOR THE ACTIVE | 30% | not scorable | Ingredient background is discussed separately. No performance score is assigned to an untested service or to a prescription that varies by patient. |
| FORMULATION INTEGRITY | 20% | not scorable | The exact dispensed preparation, manufacturer or patient-specific base was not inspected. |
| DISCLOSURE | 15% | 85/100 | Publicly defines standard and priority prices, separate medication costs, messaging duration and periodic paid reassessment. Clinical performance and individual treatment remain unassessed. |
| TOLERANCE IN USE | 15% | not scorable | No patient panel or personal treatment course. Cannot infer tolerability from ingredient names or testimonials. |
| TEXTURE & WEAR | 10% | not scorable | No product-in-hand testing. |
| COST PER APPLICATION | 10% | not scorable | Published fees are compared in the text. Actual dispensed quantity, application amount and usable duration are needed for this criterion. |

_A criterion that cannot be assessed from published information is not guessed at. Its weight is removed from the denominator, and the coverage figure above says how much of the model survived._

## Strengths

- Clearly separates visit charges from pharmacy charges.
- Publishes a follow-up messaging window.
- Explains that some conditions need in-person care.

## Weaknesses

- The initial visit does not provide indefinite refills.
- Priority pricing adds cost without guaranteeing a different clinical outcome.
- A photo assessment cannot deliver an examination or procedure that must happen in person.

## Suits

- Someone seeking a non-emergency skin assessment with a defined messaging period.
- Someone who can arrange pharmacy payment separately.

## Avoid if

- You need a procedure or an in-person examination.
- You want the service to bill your medical insurance for the visit.

## The full assessment

### What the two prices mean

The standard visit is listed at $59, with review within 24 hours; priority is $129, with review within 12 hours. Both list 30 days of follow-up messaging. These are DocBright's advertised terms, not response times measured by this site. Paying for priority changes the expected review window, so decide whether that timing is valuable before choosing it.

### Refills are not indefinite

The pricing section says prescriptions may cover up to six months when medically appropriate and that ongoing treatment requires a paid follow-up at least every six months. A medication may need attention sooner. Put the expected review date in the same calendar as the refill date rather than assuming the original visit remains active for the life of the prescription.

We classify this as a prescription-access review. No single active ingredient or fixed cream is being purchased at the visit stage. A resulting plan can vary, and any compound proposed by the clinician needs its own ingredient and pharmacy information. The classification does not assert that every possible prescription is manufactured.

**COMPARE FOLLOW-UP TERMS**

- [R-61 DermatologistOnCall Online Dermatology Visit](/reviews/dermatologistoncall-online-visit-review) — CONDITIONAL 80/100 — Another service with a stated messaging window and a one-condition rule.
- [R-62 SkyMD Online Dermatology](/reviews/skymd-online-dermatology-review) — CONDITIONAL 80/100 — A different follow-up window and an insurance-based option.

### The prescription is a second transaction

Medication is separately charged and may use insurance at the pharmacy. That leaves two checks: whether the visit price suits your budget, and whether the proposed medicine is affordable at the dispensing pharmacy. Ask about an alternative if the pharmacy quote is unexpectedly high; paying for an assessment does not obligate you to fill an unaffordable prescription without discussion.

### What we would clarify during intake

Explain what has already been tried and what happened, especially if an earlier prescription caused irritation or failed to help. Ask whether the current concern is suitable for photographs and how to arrange further assessment if it is not. DocBright describes referral for problems needing in-person care; our review cannot determine how that process would work for your location.

## Where to buy

| Retailer | Price | Link | Note | Commission-bearing |
| --- | --- | --- | --- | --- |
| DocBright | $59 / visit | https://www.docbright.com/ | Standard review; pharmacy charges extra. | no |

Prescribing is conditional on medical assessment. Advertised turnaround has not been independently tested.

**Also featured:** [CoreAge Rx skincare](https://try.coreagerx.com/skincare?utm_source=30plusskin&utm_medium=affiliate&utm_campaign=review&utm_content=docbright-online-dermatology-review&utm_term=markdown) — Browse CoreAge Rx's prescription skincare range for concerns including fine lines, dark spots, blemishes and more.

## Sources

- [DocBright — service, pricing and FAQs](https://www.docbright.com/) — $59 standard and $129 priority visits, medication billed separately, 30-day messaging, six-month reassessment requirement and in-person referral policy. Advertised response times are not independently tested. Checked 13 September 2026.

## Related records

- [PROFILE DocBright](/brands/docbright)
- [L-15 Online prescription skincare companies: compare the route to care](/ledger/online-prescription-skincare-companies)
- [L-13 What prescription skincare really costs: count the visit and the refill](/ledger/prescription-skincare-total-cost)

---

## PROMOTIONAL SPOTLIGHT: Explore CoreAge Rx skincare

More options for your skin. A patient community to connect with along the way.

**Five skincare options to explore** — Browse CoreAge Rx's prescription skincare range for concerns including fine lines, dark spots, blemishes and more.

**Connect with other patients** — Explore the CoreAge Rx patient community for shared experiences, conversations and support beyond your daily routine.

[CHECK OUT COREAGE RX SKINCARE](https://try.coreagerx.com/skincare?utm_source=30plusskin.care&utm_medium=affiliate&utm_campaign=skincare_reviews&utm_content=reading_footer)

[EXPLORE THE PATIENT COMMUNITY](https://community.coreagerx.com/)

[Read our CoreAge Rx reviews](/reviews/coreage-rx-skincare-review)

Prescription options require a clinician's assessment. Compounded medications are not FDA-approved. Community discussions do not replace medical advice.

[Product range](https://help.coreagerx.com/medication/coreage-rx-prescription-skincare) · [Community information](https://www.coreagerx.com/contact-us/)

[About promotional placements](/disclosure)

---

## Elsewhere in the register

- [Review register](/reviews)
- [Active monographs](/actives)
- [Brand register](/brands)
- [Evidence register](/evidence)
- [The ledger](/ledger)
- [How we test](/how-we-test)
- [Agent guide](/llms.txt)
- [Sitemap](/sitemap.xml)

_SOURCE-BASED ASSESSMENTS. PUBLISHER PREFERENCES ARE IDENTIFIED SEPARATELY._